We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Watson’s Quality Control Log Cited in Form 483
Watson’s Quality Control Log Cited in Form 483
February 2, 2010
FDA investigators have found Watson Laboratories’ Davie, Fla., facility failed to submit data in an ANDA showing its 30-mg amphetamine extended-release capsules failed a bioequivalency study.